January | View Newsletter

February | View Newsletter

March | View Newsletter

Includes:

• Overall Survival Analysis of SPARC Trial

• Patients Often Get Contraindicated Therapy

• Us TOO’s 2008 Board Members/Officers

• Post-Prostatectomy Incontinence Treatment

• Letter to the Editor

• Doc Moyad’s What Works and What is Worthless Column—Statins

• Read more..

Includes:

• Senate Passes Last-Minute ‘Rescue” for Doctors Facing Big Medicare Cuts

• Aspirin Impairs Prostate Cancer Treatment

• More FDA Action Possible for ESAs

• Cancer Tool Shows Promise in Scottsdale

• Hormones Delay Prostate Cancer Growth

• Research Yields Clues to Cancer Recurrence

• Read more..

Includes:

• Supreme Court Declines Review in the Abigail Alliance Experimental Drug Case

• Editorial: Provenge Pressure Builds on FDA

• Cell Genesys’ Clinical Trials to Continue

• Supreme Court Sides with Washington University in Tissue Ownership Case

• No Link Between Androgen and Risk for PCa

• Us TOO Raises Minority Cancer Awareness

• Read more..

April  | View Newsletter

MAY  | View Newsletter

June  | View Newsletter

Includes:

• Special Burning Issues Supplement: Highlights from ASCO’s 2008 Genitourinary Cancers Symposium—San Francisco, CA, February 14-16, 2008

• New Analysis Out on Cancer Drug

• GTx’s Toremifene Meets Primary Endpoints

• Treatment Decision-Making Not Easy

• The Power of Words for Cancer Patients

• April Brings a New Look to SEA Blue for National Minority Cancer Awareness Week

• Genetic Variants Found to be Associated with Prostate Cancer

• Read more..

Includes:

• Doctors Use “GPS for the Body” to Target Cancer Cells

• Takeda, Cell Genesys Partner to Develop Prostate Cancer Vaccine

• Blood Test Indicates Nodal Spread in Localized Prostate Cancer

• Medicare Changes Influenced Prostate Cancer Treatment Decisions

• New Information Drives Changes in Bladder Control Treatment

• Outer–Course vs. Inter-Course

• Geneve Bio Developing Revolutionary Curative ED Treatment

• Read more..

Includes:

• Experimental Vaccine Shows Promise in Prostate Cancer

• Celebrex-Lipitor Combination May Halt Prostate Cancer

• Prostate Cancer Mortality Declining Faster in the United States than in Britain

• Iowa, Arizona Expand on SEA Blue African American Awareness Campaign

• Similar Survival with Salvage Surgery (RP) and Radiotherapy (RT)

• Gene Activity and Cancer’s Racial Divide

• Nanotechnology Enhances Early Detection of Prostate Cancer in Black Males

• Read more..

July   | View Newsletter

August   | View Newsletter

September   | View Newsletter

Includes:

• New Analysis Boost’s Finasteride’s Value

• Active Surveillance Still a Viable Option

• Adjuvant Radiation Shows Promise for High-Risk Surgery Patients

• Kennedy Has Major Cancer Bill in Senate

• Prostate Cancer Vaccine Linked to Improved Survival in Small Trial

• Amgen Reports Positive Data at ASCO for Denosumab in Cancer Patients

• ‘Equivocal’ Antioxidant Effects in Cancer Therapy

• Read more..

Includes:

• Pints for Prostates Delivers Men’s Health Message

• Mrs. Illinois 2008 Supports Prostate Cancer Awareness and Us TOO International

• Proscar® Lowers Prostate Cancer Risk in All Men

• Radiation May Help After Prostate Cancer Setback

• GPC Biotech Announces NCI-Sponsored Phase 2 Trial of Satraplatin in Metastatic HRPC

• Doc Moyad’s “What Works and What Is Worthless Column”—Saturated Fat

• Read more..

Includes:

• Prostate Test Advice for Elderly Won’t Stop Debate

• First Annual Edward C. Kaps Hope Award Winners Announced

• Amgen Announces Positive Results for Denosumab

• Do You Know Where Your Prostate Cancer Tissue Is?

• Early Findings Create Buzz for Potent Novel Hormone Blocker

• Us TOO Seeks Board Member Nominations

• Read more..

October

November 

December